We are live on ! Find out more
TLSA icon

Tiziana Life Sciences
TLSA

5 hedge funds and large institutions have $3.89M invested in Tiziana Life Sciences in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

67% more funds holding

Funds holding: 3 → 5 (+2)

36% more capital invested

Capital invested by funds: $2.87M → $3.89M (+$1.02M)

0.24% more ownership

Funds ownership: 0.4% → 0.63% (+0.24%)

Holders
5
Holders Change
+2
Holders Change %
+66.67%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HighTower Advisors
HighTower Advisors
Illinois
+$1.29M
2
Citadel Advisors
Citadel Advisors
Florida
+$81.5K
3
HAG
HighPoint Advisor Group
Illinois
+$58K
4
TCM
Tradewinds Capital Management
Washington
+$12

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$4.32K

TLSA Hedge Fund Activity: Q1 2019 in Review

5 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Tiziana Life Sciences (TLSA) for Q1 2019, worth a combined $3.89M — up 36% from $2.87M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new TLSA positions and 0 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.

The largest buyer was HighTower Advisors, adding an estimated $1.29M. The largest seller was UBS Group, cutting an estimated $4.32K.

  • 5 institutional investors held Tiziana Life Sciences (TLSA) as of Q1 2019, up from 3 in Q4 2018.
  • Funds reported $3.89M of Tiziana Life Sciences stock for Q1 2019, up 36% quarter-over-quarter.
  • 2 funds opened new Tiziana Life Sciences positions in Q1 2019 and 0 closed out, a net change of +2 holders.
  • The largest Tiziana Life Sciences buyer in Q1 2019 was HighTower Advisors, an estimated $1.29M added.
  • The largest Tiziana Life Sciences seller in Q1 2019 was UBS Group, an estimated $4.32K sold.

Based on aggregated 13F filings for Q1 2019.